Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Longitudinal Evaluation of Visual Function in Multiple Sclerosis.
Optic Neuritis, its Differential Diagnosis and Management.
Unemployment among women with multiple sclerosis: the role of coping and perceived stress and support in the workplace.
Prediction of antibody persistency from antibody titres to natalizumab.
7 tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.
U.S. Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005-2007.
BRBN-T validation: adaptation of the Selective Reminding Test and Word List Generation.
Multiple sclerosis: IgM bands indicate reduced risk of PML on natalizumab.
Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability.
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial.
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).
Absence of Multiple Sclerosis and Demyelinating Diseases among Lacandonians, a Pure Amerindian Ethnic Group in Mexico.
Voiding dysfunction in patients with neuromyelitis optica spectrum disorders.
Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling.
Improving Safety and Operational Efficiency in Residential Care Settings With WiFi-Based Localization.
Alemtuzumab for multiple sclerosis: a new age of immunotherapy.
Transanal irrigation for bowel symptoms in patients with multiple sclerosis.
The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain.
Self-Efficacy as a Longitudinal Predictor of Perceived Cognitive Impairment in Individuals with Multiple Sclerosis.
[An update on the treatment options for multiple sclerosis].
Water Extract from the Leaves of Withania somnifera Protect RA Differentiated C6 and IMR-32 Cells against Glutamate-Induced Excitotoxicity.
The fatigue-motor performance paradox in multiple sclerosis.
Bioinformatics Mining and Modeling Methods for the Identification of Disease Mechanisms in Neurodegenerative Disorders.
From depression to neurodegeneration and heart failure: re-examining the potential of MAO inhibitors.
Onset of clinical and MRI efficacy occurs early after fingolimod treatment initiation in relapsing multiple sclerosis.
Pages
« first
‹ previous
…
293
294
295
296
297
298
299
300
301
…
next ›
last »